<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35163711</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>04</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Enhanced Expression of TRAP1 Protects Mitochondrial Function in Motor Neurons under Conditions of Oxidative Stress.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1789</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23031789</ELocationID><Abstract><AbstractText>TNF-receptor associated protein (TRAP1) is a cytoprotective mitochondrial-specific member of the Hsp90 heat shock protein family of protein chaperones that has been shown to antagonise mitochondrial apoptosis and oxidative stress, regulate the mitochondrial permeability transition pore and control protein folding in mitochondria. Here we show that overexpression of TRAP1 protects motor neurons from mitochondrial dysfunction and death induced by exposure to oxidative stress conditions modelling amyotrophic lateral sclerosis (ALS). ALS is a fatal neurodegenerative disease in which motor neurons degenerate, leading to muscle weakness and atrophy and death, typically within 3 years of diagnosis. In primary murine motor neurons, shRNA-mediated knockdown of TRAP1 expression results in mitochondrial dysfunction but does not further exacerbate damage induced by oxidative stress alone. Together, these results show that TRAP1 may be a potential therapeutic target for neurodegenerative diseases such as ALS, where mitochondrial dysfunction has been shown to be an early marker of pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Benjamin E</ForeName><Initials>BE</Initials><Identifier Source="ORCID">0000-0001-5775-352X</Identifier><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London (UCL), London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Centre for Neuromuscular Disease, London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalmar</LastName><ForeName>Bernadett</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>MRC Centre for Neuromuscular Disease, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greensmith</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London (UCL), London WC1N 3BG, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Centre for Neuromuscular Disease, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018841">HSP90 Heat-Shock Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018841" MajorTopicYN="N">HSP90 Heat-Shock Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TRAP1</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35163711</ArticleId><ArticleId IdType="pmc">PMC8836445</ArticleId><ArticleId IdType="doi">10.3390/ijms23031789</ArticleId><ArticleId IdType="pii">ijms23031789</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kalmar B., Greensmith L. Cellular Chaperones as Therapeutic Targets in ALS to Restore Protein Homeostasis and Improve Cellular Function. Front. Mol. Neurosci. 2017;10:251. doi: 10.3389/fnmol.2017.00251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00251</ArticleId><ArticleId IdType="pmc">PMC5596081</ArticleId><ArticleId IdType="pubmed">28943839</ArticleId></ArticleIdList></Reference><Reference><Citation>Song H.Y., Dunbar J.D., Zhang Y.X., Guo D., Donner D.B. Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J. Biol. Chem. 1995;270:3574&#x2013;3581. doi: 10.1074/jbc.270.8.3574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.8.3574</ArticleId><ArticleId IdType="pubmed">7876093</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.F., Chen Y., Dai K., Chen P.L., Riley D.J., Lee W.H. A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock. Mol. Cell. Biol. 1996;16:4691&#x2013;4699. doi: 10.1128/MCB.16.9.4691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.16.9.4691</ArticleId><ArticleId IdType="pmc">PMC231469</ArticleId><ArticleId IdType="pubmed">8756626</ArticleId></ArticleIdList></Reference><Reference><Citation>Cechetto J.D., Gupta R.S. Immunoelectron Microscopy Provides Evidence That Tumor Necrosis Factor Receptor-Associated Protein 1 (TRAP-1) Is a Mitochondrial Protein Which Also Localizes at Specific Extramitochondrial Sites. Exp. Cell Res. 2000;260:30&#x2013;39. doi: 10.1006/excr.2000.4983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/excr.2000.4983</ArticleId><ArticleId IdType="pubmed">11010808</ArticleId></ArticleIdList></Reference><Reference><Citation>Pridgeon J.W., Olzmann J., Chin L.-S., Li L. PINK1 Protects against Oxidative Stress by Phosphorylating Mitochondrial Chaperone TRAP1. PLoS Biol. 2007;5:e172. doi: 10.1371/journal.pbio.0050172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0050172</ArticleId><ArticleId IdType="pmc">PMC1892574</ArticleId><ArticleId IdType="pubmed">17579517</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang B.-H. TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors. BMB Rep. 2012;45:1&#x2013;6. doi: 10.5483/BMBRep.2012.45.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2012.45.1.1</ArticleId><ArticleId IdType="pubmed">22281005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang B.H., Plescia J., Dohi T., Rosa J., Doxsey S.J., Altieri D.C. Regulation of Tumor Cell Mitochondrial Homeostasis by an Organelle-Specific Hsp90 Chaperone Network. Cell. 2007;131:257&#x2013;270. doi: 10.1016/j.cell.2007.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.08.028</ArticleId><ArticleId IdType="pubmed">17956728</ArticleId></ArticleIdList></Reference><Reference><Citation>Agorreta J., Hu J., Liu D., Delia M., Turley H., Ferguson D.J.P., Iborra F., Pajares M.J., Larrayoz M., Zudaire I., et al. TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC. Mol. Cancer Res. 2014;12:660&#x2013;669. doi: 10.1158/1541-7786.MCR-13-0481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-13-0481</ArticleId><ArticleId IdType="pmc">PMC5207305</ArticleId><ArticleId IdType="pubmed">24567527</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzzo G., Sciacovelli M., Bernardi P., Rasola A. Inhibition of succinate dehydrogenase by the mitochondrial chaperone TRAP1 has anti-oxidant and anti-apoptotic effects on tumor cells. Oncotarget. 2014;5:11897&#x2013;11908. doi: 10.18632/oncotarget.2472.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.2472</ArticleId><ArticleId IdType="pmc">PMC4323003</ArticleId><ArticleId IdType="pubmed">25564869</ArticleId></ArticleIdList></Reference><Reference><Citation>Basit F., Van Oppen L.M.P.E., Sch&#xf6;ckel L., Bossenbroek H.M., Van Emst-de Vries S.E., Hermeling J.C.W., Grefte S., Kopitz C., Heroult M., Willems P.H., et al. Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells. Cell Death Dis. 2017;8:e2716. doi: 10.1038/cddis.2017.133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2017.133</ArticleId><ArticleId IdType="pmc">PMC5386536</ArticleId><ArticleId IdType="pubmed">28358377</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramov A.Y., Berezhnov A.V., Fedotova E.I., Zinchenko V.P., Dolgacheva L.P. Interaction of misfolded proteins and mitochondria in neurodegenerative disorders. Biochem. Soc. Trans. 2017;45:1025&#x2013;1033. doi: 10.1042/BST20170024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20170024</ArticleId><ArticleId IdType="pubmed">28733489</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald J.C., Zimprich A., Berrio D.A.C., Schindler K.M., Maurer B., Schulte C., Bus C., Hauser A.-K., K&#xfc;bler M., Lewin R., et al. Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson&#x2019;s disease. Brain. 2017;140:2444&#x2013;2459. doi: 10.1093/brain/awx202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx202</ArticleId><ArticleId IdType="pubmed">29050400</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler E.K., Voigt A., Lutz A.K., Toegel J.P., Gerhardt E., Karsten P., Falkenburger B., Reinartz A., Winklhofer K.F., Schulz J.B. The Mitochondrial Chaperone Protein TRAP1 Mitigates &#x3b1;-Synuclein Toxicity. PLoS Genet. 2012;8:e1002488. doi: 10.1371/journal.pgen.1002488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002488</ArticleId><ArticleId IdType="pmc">PMC3271059</ArticleId><ArticleId IdType="pubmed">22319455</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieran D., Kalmar B., Dick J.R.T., Riddoch-Contreras J., Burnstock G., Greensmith L. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat. Med. 2004;10:402&#x2013;405. doi: 10.1038/nm1021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1021</ArticleId><ArticleId IdType="pubmed">15034571</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp P.S., Akbar M.T., Bouri S., Senda A., Joshi K., Chen H.-J., Latchman D.S., Wells D.J., de Belleroche J. Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression. Neurobiol. Dis. 2008;30:42&#x2013;55. doi: 10.1016/j.nbd.2007.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.12.002</ArticleId><ArticleId IdType="pubmed">18255302</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry S.W., Norman J.P., Barbieri J., Brown E.B., Gelbard H.A. Mitochondrial membrane potential probes and the proton gradient: A practical usage guide. BioTechniques. 2011;50:98&#x2013;115. doi: 10.2144/000113610.</Citation><ArticleIdList><ArticleId IdType="doi">10.2144/000113610</ArticleId><ArticleId IdType="pmc">PMC3115691</ArticleId><ArticleId IdType="pubmed">21486251</ArticleId></ArticleIdList></Reference><Reference><Citation>Baqri R.M., Pietron A.V., Gokhale R.H., Turner B.A., Kaguni L.S., Shingleton A.W., Kunes S., Miller K.E. Mitochondrial chaperone TRAP1 activates the mitochondrial UPR and extends healthspan in Drosophila. Mech. Ageing Dev. 2014;141&#x2013;142:35&#x2013;45. doi: 10.1016/j.mad.2014.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2014.09.002</ArticleId><ArticleId IdType="pmc">PMC4310785</ArticleId><ArticleId IdType="pubmed">25265088</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa A.C., Loh S.H.Y., Martins L.M. Drosophila Trap1 protects against mitochondrial dysfunction in a PINK1/parkin model of Parkinson&#x2019;s disease. Cell Death Dis. 2013;4:e467. doi: 10.1038/cddis.2012.205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2012.205</ArticleId><ArticleId IdType="pmc">PMC3563993</ArticleId><ArticleId IdType="pubmed">23328674</ArticleId></ArticleIdList></Reference><Reference><Citation>Serapian S.A., Sanchez-Mart&#xed;n C., Moroni E., Rasola A., Colombo G. Targeting the mitochondrial chaperone TRAP1: Strategies and therapeutic perspectives. Trends Pharmacol. Sci. 2021;42:566&#x2013;576. doi: 10.1016/j.tips.2021.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2021.04.003</ArticleId><ArticleId IdType="pubmed">33992469</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciacovelli M., Guzzo G., Morello V., Frezza C., Zheng L., Nannini N., Calabrese F., Laudiero G., Esposito F., Landriscina M., et al. The Mitochondrial Chaperone TRAP1 Promotes Neoplastic Growth by Inhibiting Succinate Dehydrogenase. Cell Metab. 2013;17:988&#x2013;999. doi: 10.1016/j.cmet.2013.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2013.04.019</ArticleId><ArticleId IdType="pmc">PMC3677096</ArticleId><ArticleId IdType="pubmed">23747254</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida S., Tsutsumi S., Muhlebach G., Sourbier C., Lee M.-J., Lee S., Vartholomaiou E., Tatokoro M., Beebe K., Miyajima N., et al. Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis. Proc. Natl. Acad. Sci. USA. 2013;110:E1604&#x2013;E1612. doi: 10.1073/pnas.1220659110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1220659110</ArticleId><ArticleId IdType="pmc">PMC3637790</ArticleId><ArticleId IdType="pubmed">23564345</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A., Dai L., Liu Y., Lee J., Ghahhari N.M., Segala G., Beebe K., Jenkins L.M., Lyons G.C., Bernasconi L., et al. The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis. BMC Biol. 2020;18:10. doi: 10.1186/s12915-020-0740-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-020-0740-7</ArticleId><ArticleId IdType="pmc">PMC6986101</ArticleId><ArticleId IdType="pubmed">31987035</ArticleId></ArticleIdList></Reference><Reference><Citation>Masgras I., Sanchez-Martin C., Colombo G., Rasola A. The Chaperone TRAP1 As a Modulator of the Mitochondrial Adaptations in Cancer Cells. Front. Oncol. 2017;7:58. doi: 10.3389/fonc.2017.00058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2017.00058</ArticleId><ArticleId IdType="pmc">PMC5370238</ArticleId><ArticleId IdType="pubmed">28405578</ArticleId></ArticleIdList></Reference><Reference><Citation>Gesualdi N.M., Chirico G., Pirozzi G., Costantino E., Landriscina M., Esposito F. Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. Stress. 2007;10:342&#x2013;350. doi: 10.1080/10253890701314863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10253890701314863</ArticleId><ArticleId IdType="pubmed">17853063</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha-Oliveira T., Montezinho L., Mendes C., Firuzi O., Saso L., Oliveira P.J., Silva F.S.G. Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxidative Med. Cell. Longev. 2020;2020:5021694. doi: 10.1155/2020/5021694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5021694</ArticleId><ArticleId IdType="pmc">PMC7683149</ArticleId><ArticleId IdType="pubmed">33274002</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Tai P.W.L., Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 2019;18:358&#x2013;378. doi: 10.1038/s41573-019-0012-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-019-0012-9</ArticleId><ArticleId IdType="pmc">PMC6927556</ArticleId><ArticleId IdType="pubmed">30710128</ArticleId></ArticleIdList></Reference><Reference><Citation>Camu W., Henderson C.E. Purification of embryonic rat motoneurons by panning on a monoclonal antibody to the low-affinity NGF receptor. J. Neurosci. Methods. 1992;44(1):59&#x2013;70. doi: 10.1016/0165-0270(92)90114-S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-0270(92)90114-S</ArticleId><ArticleId IdType="pubmed">1434751</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland L.G., Nirmalananthan N., Yip J., Greensmith L., Duchen M.R. Expression of mutant SOD1G93Ain astrocytes induces functional deficits in motoneuron mitochondria. J. Neurochem. 2008;107:1271&#x2013;1283. doi: 10.1111/j.1471-4159.2008.05699.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05699.x</ArticleId><ArticleId IdType="pubmed">18808448</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou E., Fujisawa S., Barlas A., Romin Y., Manova-Todorova K., Moore M.A., Subramanian S. Tunneling Nanotubes. Commun. Integr. Biol. 2012;5:399&#x2013;403. doi: 10.4161/cib.20569.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cib.20569</ArticleId><ArticleId IdType="pmc">PMC3460850</ArticleId><ArticleId IdType="pubmed">23060969</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>